Unregulated Stem Cell Clinics Endanger Patients And Limit Research

In 2016, the Food and Drug Administration brought to the public’s attention a growing issue across the nation— experimental stem cell clinics. These for-profit clinics offer stem cell therapies with the claim of curing anything from COVID-19 and Alzheimer’s to hair loss and aging. Currently, there are nearly 1,500 businesses with 3,000 clinics across the country that offer unapproved stem cell treatments.

Stem cell technology has real potential to bring forth a new age of medicine. Research has shown promising results for stem cells as a treatment for many of the diseases that these clinics hope to cure. However, the process of creating a new drug or medical treatment that is safe and effective requires many years of experimentation and clinical trials before approval. As of now, the only stem cell therapy that has been approved for clinical application is the use of bone marrow or blood stem cells as blood marrow replacements for patients with cancer.

The vast majority of clinics currently advertising stem cell treatments are not approved by the FDA, are unaccredited, and are not reimbursed by insurance.

Read the full article on Forbes.

© William A. Haseltine, PhD. All Rights Reserved.